COURTNEY VANDERBROEK: Open Payments
NPI 1669014130 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,032 in 78 payments from 15 companies in 2025. Trend: 2023 $1,310 · 2024 $1,389 · 2025 $2,032
Food & beverage: $2,032
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $367 |
| GENZYME CORPORATION | 6 | $351 |
| EMD Serono, Inc. | 3 | $246 |
| PFIZER INC. | 9 | $206 |
| Eisai Inc. | 4 | $179 |
| TG Therapeutics, Inc. | 3 | $177 |
| Celgene Corporation | 10 | $162 |
| Novartis Pharmaceuticals Corporation | 10 | $152 |
| UCB, Inc. | 2 | $48 |
| Lundbeck LLC | 2 | $41 |
Products named: QULIPTA, Mavenclad, Leqembi, BRIUMVI, ZEPOSIA, KESIMPTA, NURTEC ODT, ZAVZPRET.
Industry payments across MI — which companies pay providers there.
